The Gardasil 9 vaccine is highly recommended for both males and females aged 9-26 years to prevent dangerous diseases related to the genital tract. For males, it is given in 2 doses, 6-12 months apart, while for females it is given in 3 doses. The FDA has approved its use for both genders to prevent genital warts, cervical, vaginal, and anal cancers. The vaccine has also been approved for use in the LGBT community. Its effectiveness can last up to 30 years for men who have received the recommended 3 doses. The vaccine is safe for both males and females aged 9-26 years old, with a recommended 3-dose regimen for those aged 9-14. Gardasil 9 protects against 9 HPV strains that are associated with most cases of genital warts and cancers, but it is still important to receive regular screenings for these diseases.